(Q39979176)

English

Relationship between retention of a vascular endothelial growth factor receptor 2 (VEGFR2)-targeted ultrasonographic contrast agent and the level of VEGFR2 expression in an in vivo breast cancer model

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Relationship between retention of a vascular endothelial growth factor receptor 2 (VEGFR2)-targeted ultrasonographic contrast agent and the level of VEGFR2 expression in an in vivo breast cancer model (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Debbie J Lee

1

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Andrej Lyshchik

2

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Jessica Huamani

3

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Dennis E Hallahan

4

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Arthur C Fleischer

5

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 June 2008

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Journal of Ultrasound in Medicine

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

855-866

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Tumor angiogenesis: therapeutic implications

1 reference

https://api.crossref.org/works/10.7863%2FJUM.2008.27.6.855

21 January 2018

Angiogenic factors

1 reference

https://api.crossref.org/works/10.7863%2FJUM.2008.27.6.855

21 January 2018

Monitoring response to anticancer therapy by targeting microbubbles to tumor vasculature

1 reference

https://api.crossref.org/works/10.7863%2FJUM.2008.27.6.855

21 January 2018

Molecular-functional imaging of cancer: to image and imagine

1 reference

https://api.crossref.org/works/10.7863%2FJUM.2008.27.6.855

21 January 2018

Quantification of tumor vascularity with contrast-enhanced sonography: correlation with magnetic resonance imaging and fluorodeoxyglucose autoradiography in an implanted tumor.

1 reference

https://api.crossref.org/works/10.7863%2FJUM.2008.27.6.855

21 January 2018

Angiogenesis: noninvasive quantitative assessment with contrast-enhanced functional US in murine model

1 reference

https://api.crossref.org/works/10.7863%2FJUM.2008.27.6.855

21 January 2018

Noninvasive assessment of angiogenesis by ultrasound and microbubbles targeted to alpha(v)-integrins

1 reference

https://api.crossref.org/works/10.7863%2FJUM.2008.27.6.855

21 January 2018

Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3.

1 reference

https://api.crossref.org/works/10.7863%2FJUM.2008.27.6.855

21 January 2018

The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.7863%2FJUM.2008.27.6.855

21 January 2018

Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis

1 reference

https://api.crossref.org/works/10.7863%2FJUM.2008.27.6.855

21 January 2018

Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization

1 reference

https://api.crossref.org/works/10.7863%2FJUM.2008.27.6.855

21 January 2018

Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

1 reference

https://api.crossref.org/works/10.7863%2FJUM.2008.27.6.855

21 January 2018

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

1 reference

https://api.crossref.org/works/10.7863%2FJUM.2008.27.6.855

21 January 2018

Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.

1 reference

https://api.crossref.org/works/10.7863%2FJUM.2008.27.6.855

21 January 2018

Homologous up-regulation of KDR/Flk-1 receptor expression by vascular endothelial growth factor in vitro.

1 reference

https://api.crossref.org/works/10.7863%2FJUM.2008.27.6.855

21 January 2018

VEGF-VEGF receptor complexes as markers of tumor vascular endothelium

1 reference

https://api.crossref.org/works/10.7863%2FJUM.2008.27.6.855

21 January 2018

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.7863%2FJUM.2008.27.6.855

21 January 2018

Trends in breast cancer by race and ethnicity: update 2006.

1 reference

https://api.crossref.org/works/10.7863%2FJUM.2008.27.6.855

21 January 2018

Ultrastructural localization of the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) receptor-2 (FLK-1, KDR) in normal mouse kidney and in the hyperpermeable vessels induced by VPF/VEGF-expressing tumors and adenoviral vect

1 reference

https://api.crossref.org/works/10.7863%2FJUM.2008.27.6.855

21 January 2018

Molecular imaging of vascular endothelial growth factor receptor 2 expression using targeted contrast-enhanced high-frequency ultrasonography

1 reference

https://api.crossref.org/works/10.7863%2FJUM.2008.27.6.855

21 January 2018

Down-regulation of platelet endothelial cell adhesion molecule-1 results in thrombospondin-1 expression and concerted regulation of endothelial cell phenotype

1 reference

https://api.crossref.org/works/10.7863%2FJUM.2008.27.6.855

21 January 2018

Intraislet endothelial cells contribute to revascularization of transplanted pancreatic islets

1 reference

https://api.crossref.org/works/10.7863%2FJUM.2008.27.6.855

21 January 2018

Tumor-specific expression of vascular endothelial growth factor receptor 2 but not vascular endothelial growth factor or human epidermal growth factor receptor 2 is associated with impaired response to adjuvant tamoxifen in premenopausal breast canc

1 reference

https://api.crossref.org/works/10.7863%2FJUM.2008.27.6.855

21 January 2018

Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1/FLT1

1 reference

https://api.crossref.org/works/10.7863%2FJUM.2008.27.6.855

21 January 2018

Tumour angiogenesis and prognosis.

1 reference

https://api.crossref.org/works/10.7863%2FJUM.2008.27.6.855

21 January 2018

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.7863%2FJUM.2008.27.6.855

21 January 2018

Development of angiogenesis inhibitors to vascular endothelial growth factor receptor 2. Current status and future perspective

1 reference

https://api.crossref.org/works/10.7863%2FJUM.2008.27.6.855

21 January 2018

Differential effects of vascular endothelial growth factor receptor-2 inhibitor ZD6474 on circulating endothelial progenitors and mature circulating endothelial cells: implications for use as a surrogate marker of antiangiogenic activity.

1 reference

https://api.crossref.org/works/10.7863%2FJUM.2008.27.6.855

21 January 2018

Identifiers

10.7863/JUM.2008.27.6.855

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39979176&oldid=1881673734"